tiprankstipranks
Trending News
More News >
Ani Pharmaceuticals (ANIP)
:ANIP
US Market

ANI Pharmaceuticals (ANIP) Income Statement

Compare
335 Followers

ANI Pharmaceuticals Income Statement

Last quarter (Q3 2025), ANI Pharmaceuticals's total revenue was $227.81M, an increase of 53.58% from the same quarter last year. In Q3, ANI Pharmaceuticals's net income was $24.13M. See ANI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 614.38M$ 486.82M$ 316.38M$ 216.14M$ 208.47M
Gross Profit
$ 364.17M$ 305.30M$ 177.60M$ 115.53M$ 121.32M
Operating Expenses
$ 363.58M$ 258.33M$ 212.88M$ 155.32M$ 137.33M
Depreciation and Amortization
$ 67.73M$ 59.79M$ 59.65M$ 47.25M$ 44.64M
EBITDA
$ 63.12M$ 106.60M$ 25.04M$ 3.12M$ 28.13M
Operating Income
$ 584.00K$ 46.97M$ -35.28M$ -39.79M$ -16.02M
Other Income/Expenses
$ -22.80M$ -27.10M$ -27.38M$ -16.27M$ -9.95M
Pretax Income
$ -22.21M$ 19.87M$ -62.66M$ -56.06M$ -25.96M
Net Income
$ -18.52M$ 18.78M$ -47.90M$ -42.60M$ -22.55M
Per Share Metrics
Basic EPS
$ -1.04$ 0.95$ -3.05$ -3.40$ -1.88
Diluted EPS
$ -1.04$ 0.94$ -3.05$ -3.40$ -1.88
Weighted Average Shares Outstanding
19.32M 18.00M 16.26M 12.60M 11.96M
Weighted Average Shares Outstanding (Diluted)
19.32M 18.19M 16.26M 12.60M 11.96M
Currency in USD

ANI Pharmaceuticals Earnings and Revenue History